Trump's 200% tariff plan may be a bitter pill for US consumers; Dr Reddy's warns of costlier medicines
Join our WhatsApp Community to receive travel deals, free stays, and special offers!
- Join Now -
Join our WhatsApp Community to receive travel deals, free stays, and special offers!
- Join Now -
The United States plans significant tariffs on imported generic medicines. These duties will rise to 200% in the coming years. Dr Reddy's Laboratories anticipates higher medicine prices for American consumers. Shifting manufacturing to the US is currently considered impractical by the company. India faces substantial exposure as a major generic medicine exporter to the US. What's Your Reaction?
Like
0
Dislike
0
Love
0
Funny
0
Angry
0
Sad
0
Wow
0
